B. Metzler Seel. Sohn & Co. Ag Trans Medics Group, Inc. Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $10 Billion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 6,744 shares of TMDX stock, worth $459,333. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,744Holding current value
$459,333% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TMDX
# of Institutions
377Shares Held
31.3MCall Options Held
465KPut Options Held
286K-
Vanguard Group Inc Valley Forge, PA3.64MShares$248 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$180 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.44MShares$98.2 Million2.22% of portfolio
-
State Street Corp Boston, MA1.27MShares$86.7 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.09MShares$74.5 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.17B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...